Advanced Health Intelligence Ltd
Change company Symbol lookup
Select an option...
AHI Advanced Health Intelligence Ltd
SNTG Sentage Holdings Inc
MDGS Medigus Ltd
WLDS Wearable Devices Ltd
UP Wheels Up Experience Inc
BRTX BioRestorative Therapies Inc
FRZA Forza X1 Inc
ILMN Illumina Inc
NR Newpark Resources Inc
CGC Canopy Growth Corp

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Health Care Technology | Small Cap Blend
Based in Australia
Company profile

Advanced Human Imaging Limited is an Australia-based human imaging company. The Company offers a smartphone-based human scanning technology, with a range of data-driven applications across multiple industries. It has developed a dimensioning technology that enables its partners and their users to check, track, and assess their vital signs and dimensions using only a smartphone. Its CompleteScan platform is a multi-scan technology for its partner's smartphone application users. Its BodyScan technology is an image processing technique that returns body circumference, body composition, health risks, and risk indicators. Its FaceScan technology is a non-intrusive method for measuring vital signs, and risks associated with cardiovascular disease, heart attack and stroke. Its DermaScan technology is an intelligent, instant dermatological scanner with diagnostic capabilities, capable of screening for over 500 skin conditions. The Company offers its solutions to various industries.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Closing Price
Day's Change
1.87 (603.23%)
B/A Size
Day's High
Day's Low
(Heavy Day)

10-day average volume:

US Nuclear's Mission for Clean Air and Safe Water

8:30 am ET March 15, 2023 (Globe Newswire) Print
US Nuclear's Mission for Clean Air and Safe WaterGlobeNewswireMarch 15, 2023

LOS ANGELES, CA, March 15, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - In the US and around the world, pollution, industrial discharge, hazardous and toxic spills and various disasters are badly contaminating the air we breathe and water we drink. However, US Nuclear (OTC-QB: UCLE) is working towards a day when everyone has clean air to breathe and safe water to drink. US Nuclear is a sensor and measurement company, making and selling detectors for monitoring both air and water for anything that could be harmful, such as biological, chemical, or radiological hazards. With a variety of both portable and stationary versions available, US Nuclear's products can be used by the average homeowner as well as by emergency responders and hazmat teams. Furthermore, countries around the world are finally cracking down on air and water quality, imposing stricter limits and new testing, and investing money to make it happen.

One prime example of this is how the US is now finally addressing the dangers of PFAS contamination, with the Bipartisan Infrastructure Law investing $5 billion over 5 years to help communities monitor and reduce "forever chemicals" PFAS contamination in drinking water. To this end, US Nuclear has developed the world's first real-time PFAS monitor that can measure this class of hazardous chemicals in under a minute. US Nuclear recently showcased this product at the Indoor Air Quality Association (IAQA) and had a really great response.

Air quality is also of serious concern, especially with rising pollution and no shortage of hazardous disasters, such as train derailments and fires releasing extremely dangerous chemicals into the air. Real-time information is one of the most important things to have in these scenarios, information on exactly which hazardous chemicals are in the air, at what concentration, and the affected area. During the train derailment near Palestine, Ohio, first responders were just looking in general for the presence of VOCs (volatile organic compounds), but due to the fire, hundreds of different chemicals were released (some cancer-causing), and what was needed were instruments like US Nuclear's that can individually identify and measure a wide range of toxic airborne chemicals so that the residents and first responders can protect themselves and the community.

Safe Harbor Act

This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

Investors may find additional information regarding US Nuclear Corp. at the SEC website at, or the company's website at


US Nuclear Corp. (OTC-QB: UCLE)

Robert I. Goldstein, President, CEO, and Chairman

Richard Landry, Chief Financial Officer

(818) 883 7043


Primary Logo

comtex tracking


Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.